SLC2A1 and Stroke: Some results show that both GLUT-1 and sodium-dependent glucose transporters (SGLT) still play a role at the BBB in the blood-to-brain transport of glucose during ischemic conditions, and inhibition of SGLT during stroke has the potential to improve stroke outcome.